Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study

Por Josephine G Walker, PhD, Tinatin Kuchuloria, MD, David Sergeenko, MD, Hannah Fraser, PhD, Aaron G Lim, DPhil, Shaun Shadaker, MPH, Liesl Hagan, MPH, Amiran Gamkrelidze, ProfPhD, Valeri Kvaratskhelia, MD, Lia Gvinjilia, MD, Malvina Aladashvili, MD, Alexander Asatiani, MD, Davit Baliashvili, MD, Maia Butsashvili, ProfPhD, Ivdity Chikovani, MD, Irma Khonelidze, MD, Irma Kirtadze, PhD, Mark H Kuniholm, PhD, David Otiashvili, PhD, Lali Sharvadze, PhD, Ketevan Stvilia, MD, Tengiz Tsertsvadze, ProfPhD, Mamuka Zakalashvili, MD, Matthew Hickman, PhD, Natasha K Martin, DPhil, Juliette Morgan, MD, Muazzam Nasrullah, PhD, Francisco Averhoff, MD, Peter Vickerman, ProfDPhil
Publicado em 2020-02-01